Today’s stock pick update – Open Now

Learn More Free Stock Picking Training: The Ultimate Stock Picking System Looking to find consistency in your stock investing? Here's a little known system used by wall street pros for over a 100 years to find the best stocks in any market. (Ad) The Ultimate Stock Picking System works so well because it finds the very best stocks at the perfect time - over and over again. Mnuchin Reignites Stimulus Hopes With $916 Billion Proposal

Stimulus, again. Treasury Secretary Steven Mnuchin made a surprise re-entry into the stimulus fray, delivering a $916 billion proposal that opens up a new path to a year-end deal despite objections from Democrats over elements of his plan. Mnuchin’s $916 billion plan delivered to House Speaker Nancy Pelosi includes $600 stimulus payments to individuals, $160 billion in aid for state and local authorities, and “robust” protections for employers from COVID-19 related laws... Read More

Stitch Fix Inc (NASDAQ: SFIX): Stitch Fix shares rocketed as much as 53% yesterday following the clothing subscription service delivering an earnings beat. For its fiscal first quarter, the company reported earnings of $0.09 per share on revenue of $490.4 million, topping estimates for a loss of $0.20 per share on revenue of $481.2 million. “In Q1, we delivered $490 million in ne... Read More

SIG is an interesting retail stock to watch for 2021 It isn’t that the numbers – sales, earnings, free cash flow, debt, and so on – aren’t important, because of course they always are. They help to frame a company’s business over any given period of time in a useful context. Sometimes, however, you also need to be able to look beyond the limits of what that context may describe. It can be important to remember that the numbers that make up fundamental and value-based measurements are almost always historical in nature; even fo... Read More

Featured Stock Altimmune, Inc. (ALT) – Buy Price: $13.00 or better Altimmune, Inc., a clinical stage biopharmaceutical company, focused developing treatments for liver disease, immune modulating therapies, and vaccines. The company develops HepTcell, an immunotherapeutic product candidate that has completed Phase I clinical trial for patients chronically infected with the hepatitis B virus; NasoShield, an anthrax vaccine to provide for protection after a single intranasal administration. Read More

Other Top Stories Weeks after election, YouTube cracks down on misinformation GM's Cruise to deploy fully driverless cars in San Francisco Like everything else 2020, taxes will be like no other year Trump tries to revive stalled election-eve drug discounts Boeing 737 Max back in air 2 years after grounded by crashes

Trend Following Picks Altimmune, Inc. (ALT) – Buy Price: $13.00 or better Novavax, Inc. (NVAX) – Buy Price: $130.00 or better Glu Mobile Inc. (GLUU) – Buy Price: $10.00 or better Clean Energy Fuels Corp. (CLNE) – Buy Price: $4.50 or better Sociedad Química y Minera de Chile S.A. (SQM) – Buy Price: $47.00 or better All Picks

Reversal Picks Ashford Hospitality Trust, Inc. (AHT) Buy Target $3.53 Sell Target $4.40 Vista Gold Corp. (VGZ) Buy Target $1.07 Sell Target $1.18 Jianpu Technology Inc. (JT) Buy Target $4.73 Sell Target $6.13 PolyMet Mining Corp. (PLM) Buy Target $3.73 Sell Target $4.18 NGL Energy Partners LP (NGL) Buy Target $3.00 Sell Target $3.55 All Picks

Low Price Stock Picks Peabody Energy Corporation (BTU) Permianville Royalty Trust (PVL) Gran Tierra Energy Inc. (GTE) Milestone Scientific Inc. (MLSS) Oragenics, Inc. (OGEN) All Picks

Already subscribed to our premium service? Click here to Login. Not a TradersPro subscriber yet? Learn More About TradersPro Here - Learn The # 1 Key To Successful Stock Investing Profits

 

This email was sent to Phanhoa1821960.lomo013579@blogger.com  from TradersPro by Investiv, LLC 265 N. Main | Ste. D #283 Kaysville | UT | 84037  Unsubscribe or Mange which emails you get from TradersPro Disclaimers, Terms & Conditions | Privacy Policy Copyright 2020  Investing is Inherently Risky - There are risks inherent in all investments, which may make such investments unsuitable for certain persons. These include, for example, economic, political, currency exchange, rate fluctuations, and limited availability of information on international securities. You may lose all of your money trading and investing. Do NOT enter any trade without fully understanding the worst-case scenarios of that trade. And do NOT trade with money you cannot afford to lose. Past performance of an investment is not necessarily indicative of its future results. No assurance can be given that any implied recommendation will be profitable or will not be subject to losses.